Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist(Diphenhydramine)in Advanced and Metastatic Non-Small Cell Lung Cancer
PHASE3
The goal of this clinical trial is to learn if diphenhydramine can improve ...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma
PHASE1
The aim of this study is to analyze the safety of BAFF-R Chimeric Antigen R...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences